Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

2018 marks the 10 year anniversary since the Journal of Hematology & Oncology published its first article. Over the past decade, the journal has established itself in the top quartile of journals in both its fields worldwide.

To mark this occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 10 years.

Content type: Research
| 7 December 2018

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD

Authors: Peilong Lai, Xiaomei Chen, Liyan Guo, Yulian Wang, Xialin Liu, Yan Liu, Tian Zhou, Tian Huang, Suxia Geng, Chengwei Luo, Xin Huang, Suijing Wu, Wei Ling, Xin Du, Chang He and Jianyu Weng
Content type: Review
| 4 December 2018

FLT3 inhibitors in acute myeloid leukemia

Authors: Mei Wu, Chuntuan Li and Xiongpeng Zhu
Content type: Review
| 4 December 2018

Advances in multiple omics of natural-killer/T cell lymphoma

Authors: Jie Xiong and Wei-Li Zhao
Content type: Review
| 27 November 2018

Universal CARs, universal T cells, and universal CAR T cells

Authors: Juanjuan Zhao, Quande Lin, Yongping Song and Delong Liu
Content type: Review
| 22 November 2018

Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies

Authors: Nonthaphat Kent Wong, Chien-Ling Huang, Rashidul Islam and Shea Ping Yip

Most recent articles RSS

View all articles

Content type: Review
| 22 March 2011

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

Authors: Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin
Content type: Review
| 10 June 2009

The effects of β-glucan on human immune and cancer cells

Authors: Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze
Content type: Review
| 25 February 2013

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Authors: Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang
Content type: Review
| 19 August 2013

Ibrutinib and novel BTK inhibitors in clinical development

Authors: Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu
Content type: Review
| 30 September 2013

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Authors: Li Shi, Shaohua Chen, Lijian Yang and Yangqiu Li

Most accessed articles RSS

View all articles

Nobel winner: Dr. James P. Allison

The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation." For a previously published work by Dr. Allison in Journal of Hematology & Oncology, see this article.

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology.

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Journal of Hematology & Oncology

Celebrating a decade of the Journal of Hematology & Oncology

Articles

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD

FLT3 inhibitors in acute myeloid leukemia

Advances in multiple omics of natural-killer/T cell lymphoma

Universal CARs, universal T cells, and universal CAR T cells

Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options

The effects of β-glucan on human immune and cancer cells

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers

Ibrutinib and novel BTK inhibitors in clinical development

The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies

Nobel winner: Dr. James P. Allison

Aims and scope

Editor's quote

Experimental Hematology & Oncology

Official journal of

2017 Journal Metrics

Journal of Hematology & Oncology

Contact us